Chughtai B - Search Results

1

Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.

Cornu JN, Zantek P, Burtt G, Martin C, Martin A, Springate C, Chughtai B. Cornu JN, et al. Among authors: chughtai b. Eur Urol. 2023 Jun;83(6):534-547. doi: 10.1016/j.eururo.2023.02.028. Epub 2023 Mar 22. Eur Urol. 2023. PMID: 36964042 Review.

2

Inflammation and benign prostatic hyperplasia: clinical implications.

Chughtai B, Lee R, Te A, Kaplan S. Chughtai B, et al. Curr Urol Rep. 2011 Aug;12(4):274-7. doi: 10.1007/s11934-011-0191-3. Curr Urol Rep. 2011. PMID: 21519898 Review.

3

Role of inflammation in benign prostatic hyperplasia.

Chughtai B, Lee R, Te A, Kaplan S. Chughtai B, et al. Rev Urol. 2011;13(3):147-50. Rev Urol. 2011. PMID: 22110398 Free PMC article.

4

Effect of a risk-stratified grade of nerve-sparing technique on early return of continence after robot-assisted laparoscopic radical prostatectomy.

Srivastava A, Chopra S, Pham A, Sooriakumaran P, Durand M, Chughtai B, Gruschow S, Peyser A, Harneja N, Leung R, Lee R, Herman M, Robinson B, Shevchuk M, Tewari A. Srivastava A, et al. Among authors: chughtai b. Eur Urol. 2013 Mar;63(3):438-44. doi: 10.1016/j.eururo.2012.07.009. Epub 2012 Jul 20. Eur Urol. 2013. PMID: 22901982

5

Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia.

Chughtai B, Elterman DS, Lee R, Te AE, Kaplan SA. Chughtai B, et al. Ther Adv Urol. 2012 Oct;4(5):267-72. doi: 10.1177/1756287212457115. Ther Adv Urol. 2012. PMID: 23024707 Free PMC article.

6

Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia.

Elterman DS, Chughtai B, Lee RK, Te AE, Kaplan SA. Elterman DS, et al. Among authors: chughtai b. Rev Urol. 2012;14(3-4):79-86. Rev Urol. 2012. PMID: 23526698 Free PMC article.

7

Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.

Chughtai B, Dunphy C, Lee R, Lee D, Sheth S, Marks L, Kaplan SA, Te AE. Chughtai B, et al. Can J Urol. 2014 Apr;21(2):7217-21. Can J Urol. 2014. PMID: 24775575 Clinical Trial.

8

A meta-analysis of the performance of retropubic mid urethral slings versus transobturator mid urethral slings.

Seklehner S, Laudano MA, Xie D, Chughtai B, Lee RK. Seklehner S, et al. Among authors: chughtai b. J Urol. 2015 Mar;193(3):909-15. doi: 10.1016/j.juro.2014.09.104. Epub 2014 Oct 2. J Urol. 2015. PMID: 25281779

9

A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration.

Al Hussein Al Awamlh B, Lee R, Chughtai B, Donat SM, Sandhu JS, Herr HW. Al Hussein Al Awamlh B, et al. Among authors: chughtai b. Urology. 2015 Feb;85(2):381-6. doi: 10.1016/j.urology.2014.09.041. Urology. 2015. PMID: 25623694

10

Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes.

Hueber PA, Bienz MN, Valdivieso R, Lavigueur-Blouin H, Misrai V, Rutman M, Te AE, Chughtai B, Barber NJ, Emara AM, Munver R, Trinh QD, Zorn KC. Hueber PA, et al. Among authors: chughtai b. J Urol. 2015 Aug;194(2):462-9. doi: 10.1016/j.juro.2015.03.113. Epub 2015 Apr 4. J Urol. 2015. PMID: 25849599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page